Background. Liver transplantation recipients are at high risk of severe complications of many viral infections because they are treated with immunosuppressive drugs affecting the immune system. Vaccination for liver transplantation candidates is generally recommended before surgery, but the opportunities for vaccination prior to transplantation in pediatric candidates are often limited by severe disease conditions. The effectiveness and safety of immunization with vaccines in standard vaccination programs for pediatric liver transplantation recipients thus need to be elucidated.
Methods. Participants in this study comprised 39 pediatric recipients of living donor liver transplantation. Criteria for administering live-attenuated (measles, rubella, mumps, and varicella) and inactivated vaccines (hepatitis B, pertussis, and Japanese encephalitis) were as follows: 1) >1 year after transplantation; 2) no use of systemic steroids to treat acute rejection within the last 6 months; 3) serum trough concentration of tacrolimus <5 ng/ml; 4) no severe immunosuppression according to blood examinations; and 5) provision of written informed consent. Median age at transplantation was 17 months old and median period from transplantation to the beginning of immunization was 18 months.
Results. Seroprotection rates for measles, rubella, mumps, varicella, hepatitis B, pertussis, and Japanese encephalitis after post-transplant immunization were 31% (8/26), 70% (19/27), 48% (12/25), 37% (7/19), 83% (19/23), 87% (13/15), and 88% (7/8), respectively. Seroprotection rates for measles, rubella, mumps, and varicella after 2nd vaccination for recipients with primary vaccine failure after the first vaccination were 67% (6/9), 50% (1/2), 71% (5/7), and 50% (5/10). While 4 recipients caught the mumps and eight contracted varicella before immunization, one recipient developed varicella after immunization. No serious systemic adverse events were observed in vaccinated recipients.
Conclusion. Seroprotection rates for measles, rubella, and varicella appeared low in children after the first posttransplantation vaccination. Immunizations with four live-attenuated and three inactivated vaccines were safe and effective for pediatric liver transplantation recipients who were not severely immunosuppressed.
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